Scientific Research News

DALLAS--(BUSINESS WIRE)--The IUCN Species Survival Commission (SSC) and the Colossal Foundation, the 501(c)(3) nonprofit arm of Colossal Biosciences, today announced a four-year, $4 million partnership to expand the responsible use of advanced technologies in global species conservation. The collaboration pairs more than 11,000 IUCN SSC experts, working through 210 groups in 186 countries, with scientific and technological capabilities from across the Colossal ecosystem, while preserving IUCN S...

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-833-461-5787 International: (+1) 626-884-3620 Conference ID: 323 558 822 The live webcast can be accessed through Neo...

MALMÖ, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global patient recruitment leader advancing technology and AI, is reimagining how patients connect with clinical trials by giving them greater choice over how and when they complete secondary screening through its new AI Pre-Screening Agent in the Honey Platform™. The agent introduces a faster, more flexible path for pre-qualification and participation decisions, and engages patients at the highest moment of interest as they are a...

SAN DIEGO--(BUSINESS WIRE)--The Genome Partnership today announced the recipients of the 2026 AGBT Precision Health Next Gen Leadership Awards, recognizing emerging scientists whose research advances understanding of human disease and explores new applications of genomics, data science and artificial intelligence in precision medicine. Recipients receive support for registration, lodging and travel to attend the AGBT Precision Health Meeting, present their research and connect with leaders acro...

SANTA MONICA, Calif.--(BUSINESS WIRE)--mBIOTA Labs, an emerging medical food company advancing the science and use of medical nutrition for the management of gastrointestinal (GI) conditions, today announced the expansion of the mBIOTA Elemental Diet portfolio with the introduction of Lemon Ginger, a new flavor designed to improve the patient experience and support protocol adherence. Flavor fatigue during an exclusive elemental diet protocol can often present a potential barrier to patient com...

BOSTON--(BUSINESS WIRE)--Tufts Medicine Tufts Medical Center has been awarded a $44 million grant from the National Institutes of Health (NIH) to test a fundamentally new model of advance care planning (ACP) that begins conversations about end-of-life care earlier to give patients and caregivers more time to communicate their preferences for future medical care. These conversations will be led by social workers and nurses using video decision-support tools available in 25 languages. This grant...

PHILADELPHIA--(BUSINESS WIRE)--Bleu Garde, LLC, a science and technology company developing next-generation indoor air treatment technologies for pathogen reduction, environmental health and pandemic preparedness, today announced at the Builds Bio+ 5th Annual Philadelphia Life Science Symposium that the U.S. Environmental Protection Agency (EPA) has registered Arresta® for use as a virucidal air treatment, air sanitizer and fungistat, including use in occupied indoor spaces in accordance with i...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new agreement with the Pan American Health Organization (PAHO) to accelerate access to twice-yearly lenacapavir for HIV prevention as pre-exposure prophylaxis (PrEP) across all PAHO Member States in Latin America and the Caribbean. Through PAHO’s Regional Revolving Funds, the agreement establishes a coordinated regional pathway to expand access to long-acting HIV prevention and support country-led effor...

MIAMI & PHILADELPHIA--(BUSINESS WIRE)--OpenEvidence, the most widely used medical AI and clinical decision-making tool among U.S. physicians, and Penn Medicine today announced a global partnership to bring AI-powered clinical decision support to Penn Medicine's more than 10,000 clinicians across its seven-hospital U.S. health system. That clinical decision support will also extend to low and middle income countries through the Botswana-UPenn Partnership (BUP). Building on Penn Medicine’s deep c...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Alexandre de Germay, Chief International Commercial Officer, Executive Vice President, at the J.P. Morgan U.S. All Stars 2026 Conference on Tuesday, September 22, 2026 at 11:50 a.m. BST. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors...